Maurizio Averna
TitleCited byYear
Efficacy and safety of alirocumab in reducing lipids and cardiovascular events
JG Robinson, M Farnier, M Krempf, J Bergeron, G Luc, M Averna, ...
New England Journal of Medicine 372 (16), 1489-1499, 2015
14862015
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of …
BG Nordestgaard, MJ Chapman, SE Humphries, HN Ginsberg, L Masana, ...
European heart journal 34 (45), 3478-3490, 2013
14722013
Thromboxane biosynthesis and platelet function in type II diabetes mellitus
G Davě, I Catalano, M Averna, A Notarbartolo, A Strano, G Ciabattoni, ...
New England Journal of Medicine 322 (25), 1769-1774, 1990
7211990
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
M Cuchel, EA Meagher, H du Toit Theron, DJ Blom, AD Marais, ...
the Lancet 381 (9860), 40-46, 2013
5292013
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on …
M Cuchel, E Bruckert, HN Ginsberg, FJ Raal, RD Santos, RA Hegele, ...
European heart journal 35 (32), 2146-2157, 2014
4872014
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
A Wiegman, SS Gidding, GF Watts, MJ Chapman, HN Ginsberg, M Cuchel, ...
European heart journal 36 (36), 2425-2437, 2015
3432015
Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia
A Notarbartolo, G Davı̀, M Averna, CM Barbagallo, A Ganci, ...
Arteriosclerosis, Thrombosis, and Vascular Biology 15 (2), 247-251, 1995
3431995
A novel component of the metabolic syndrome: the oxidative stress
E Hopps, D Noto, G Caimi, MR Averna
Nutrition, Metabolism and Cardiovascular Diseases 20 (1), 72-77, 2010
3152010
A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke
F Cipollone, E Toniato, S Martinotti, M Fazia, A Iezzi, C Cuccurullo, B Pini, ...
Jama 291 (18), 2221-2228, 2004
3112004
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
RA Hegele, HN Ginsberg, MJ Chapman, BG Nordestgaard, ...
The lancet Diabetes & endocrinology 2 (8), 655-666, 2014
2842014
Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children
A Carroccio, G Iacono, M Cottone, L Di Prima, F Cartabellotta, F Cavataio, ...
Clinical chemistry 49 (6), 861-867, 2003
2452003
Increased thromboxane biosynthesis in type IIa hypercholesterolemia.
G Davi, M Averna, I Catalano, C Barbagallo, A Ganci, A Notarbartolo, ...
Circulation 85 (5), 1792-1798, 1992
2241992
Gastrointestinal symptoms in infancy: a population-based prospective study
G Iacono, R Merolla, D D’Amico, E Bonci, F Cavataio, L Di Prima, ...
Digestive and liver disease 37 (6), 432-438, 2005
1952005
Clinical expression of familial hypercholesterolemia in clusters of mutations of the LDL receptor gene that cause a receptor-defective or receptor-negative phenotype
S Bertolini, A Cantafora, M Averna, C Cortese, C Motti, S Martini, G Pes, ...
Arteriosclerosis, thrombosis, and vascular biology 20 (9), e41-e52, 2000
1572000
Comparison of anti-transglutaminase ELISAs and an anti-endomysial antibody assay in the diagnosis of celiac disease: a prospective study
A Carroccio, G Vitale, L Di Prima, N Chifari, S Napoli, C La Russa, ...
Clinical chemistry 48 (9), 1546-1550, 2002
1522002
Fatty liver in familial hypobetalipoproteinemia triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis
G Schonfeld, BW Patterson, DA Yablonskiy, TSK Tanoli, M Averna, ...
Journal of lipid research 44 (3), 470-478, 2003
1402003
Molecular diagnosis of hypobetalipoproteinemia: an ENID review
P Tarugi, M Averna, E Di Leo, AB Cefalů, D Noto, L Magnolo, L Cattin, ...
Atherosclerosis 195 (2), e19-e27, 2007
1382007
Estrogen up-regulates apolipoprotein E (ApoE) gene expression by increasing ApoE mRNA in the translating pool via the estrogen receptor α-mediated pathway
RAK Srivastava, N Srivastava, M Averna, RC Lin, KS Korach, DB Lubahn, ...
Journal of Biological Chemistry 272 (52), 33360-33366, 1997
1351997
Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: the ODYSSEY OPTIONS II …
M Farnier, P Jones, R Severance, M Averna, E Steinhagen-Thiessen, ...
Atherosclerosis 244, 138-146, 2016
1292016
European Atherosclerosis Society Consensus Panel. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to …
BG Nordestgaard, MJ Chapman, SE Humphries, HN Ginsberg, L Masana, ...
Eur Heart J 34 (45), 3478-90a, 2013
1262013
The system can't perform the operation now. Try again later.
Articles 1–20